Sellas Life Sciences: REGAL Study Results Due Any Day Are A Major Potential Upside Catalyst [Seeking Alpha]
Why I'm Selling Sellas Life Sciences Ahead Of The REGAL Reveal [Seeking Alpha]
A Look At SELLAS Life Sciences Group (SLS) Valuation After New IMPACT AML Clinical Study Agreement [Yahoo! Finance]
SELLAS Life Sciences Enters Agreement with IMPACT-AML to Expand SLS009 Clinical Program into Europe
SELLAS Life Sciences Group (SLS) Is Up 50.8% After REGAL Trial Nears Final OS Trigger - Has The Bull Case Changed? [Yahoo! Finance]